A team of researchers led by Dmitry Temiakov, PhD, of the Rowan University School of Osteopathic Medicine (RowanSOM), has discovered a molecular 'switch' that controls replication and transcription of mitochondria DNA, a key finding that could influence the development of targeted therapies for cancer, developmental processes related to fertility and aging.
from The Medical News http://ift.tt/1CzPPT3
from The Medical News http://ift.tt/1CzPPT3
No comments:
Post a Comment